Gabapentin for Chronic Neuropathic Pain
- 27 February 2018
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 319 (8), 818-819
- https://doi.org/10.1001/jama.2017.21547
Abstract
Clinical Question Is gabapentin associated with pain relief in people with chronic neuropathic pain? Bottom Line Oral gabapentin (1200-3600 mg/d for 4-12 weeks) for patients with moderate or severe neuropathic pain from postherpetic neuralgia (PHN) or painful diabetic neuropathy (PDN) is associated with pain reduction of at least 50% in 14% to 17% more patients than placebo.This publication has 5 references indexed in Scilit:
- Gabapentin for chronic neuropathic pain in adultsCochrane Database of Systematic Reviews, 2017
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisThe Lancet Neurology, 2015
- Expect analgesic failure; pursue analgesic successBMJ, 2013
- Pain measures and cut‐offs – ‘no worse than mild pain’ as a simple, universal outcomeAnaesthesia, 2013
- EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEuropean Journal of Neurology, 2010